Using an Annexin V-TITC and PI double-staining method, ACFP treatment was shown to promote human primary ovarian cancer cell apoptosis in vitro (Fig. 4) in a time- and dose- dependent manner. This evidence concerns the gene ANXA5 and ovarian carcinoma.